DE60326128D1 - Verwendung von mischungen von lipopeptiden zur bereitung von impfstoffen - Google Patents
Verwendung von mischungen von lipopeptiden zur bereitung von impfstoffenInfo
- Publication number
- DE60326128D1 DE60326128D1 DE60326128T DE60326128T DE60326128D1 DE 60326128 D1 DE60326128 D1 DE 60326128D1 DE 60326128 T DE60326128 T DE 60326128T DE 60326128 T DE60326128 T DE 60326128T DE 60326128 D1 DE60326128 D1 DE 60326128D1
- Authority
- DE
- Germany
- Prior art keywords
- lipopeptides
- vaccines
- mixtures
- preparation
- relates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0203189A FR2837104B1 (fr) | 2002-03-14 | 2002-03-14 | Utilisation de melange de lipopeptides pour la fabrication de vaccins |
PCT/FR2003/000821 WO2003075956A2 (fr) | 2002-03-14 | 2003-03-14 | Utilisation de melanges de lipopeptides pour la fabrication de vaccins |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60326128D1 true DE60326128D1 (de) | 2009-03-26 |
Family
ID=27772125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60326128T Expired - Lifetime DE60326128D1 (de) | 2002-03-14 | 2003-03-14 | Verwendung von mischungen von lipopeptiden zur bereitung von impfstoffen |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1487484B1 (de) |
JP (1) | JP2005527513A (de) |
AT (1) | ATE422366T1 (de) |
AU (1) | AU2003233377A1 (de) |
CA (1) | CA2478846A1 (de) |
DE (1) | DE60326128D1 (de) |
ES (1) | ES2322253T3 (de) |
FR (1) | FR2837104B1 (de) |
WO (1) | WO2003075956A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006313464B2 (en) * | 2005-11-11 | 2012-07-12 | Proteogen Bio S.R.L. | Method of converting water-soluble active proteins into hydrophobic active proteins, the use of the same for the preparation of monomolecular layers of oriented active proteins, and devices comprising the same |
WO2010104747A2 (en) | 2009-03-10 | 2010-09-16 | Baylor Research Institute | Antigen presenting cell targeted vaccines |
DK2406286T3 (en) | 2009-03-10 | 2016-08-22 | Baylor Res Inst | Anti-cd40 antibodies and uses thereof |
JP7037884B2 (ja) | 2014-01-13 | 2022-03-17 | ベイラー リサーチ インスティテュート | Hpv及びhpv関連疾患に対する新規のワクチン |
CN105949121A (zh) * | 2016-06-02 | 2016-09-21 | 辽宁大学 | 一种从莲子心中提取甲基莲心碱的方法及其应用 |
US10610585B2 (en) | 2017-09-26 | 2020-04-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and compositions for treating and preventing HIV |
FR3086534B1 (fr) | 2018-10-01 | 2020-11-06 | Univ Bordeaux | Methode pour traiter une infection par le virus de l'immunodeficience humaine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2797632B1 (fr) * | 1999-08-19 | 2003-01-24 | Dutel Sa | Fonctionnalisation d'un peptide par un groupement alpha- hydrazinoacetique |
AUPQ776100A0 (en) * | 2000-05-26 | 2000-06-15 | Australian National University, The | Synthetic molecules and uses therefor |
FR2813794B1 (fr) * | 2000-09-08 | 2003-01-24 | Pasteur Institut | Procede de couplage, en solution, entre un peptide et un vecteur lipophile et ses applications |
-
2002
- 2002-03-14 FR FR0203189A patent/FR2837104B1/fr not_active Expired - Fee Related
-
2003
- 2003-03-14 EP EP03727589A patent/EP1487484B1/de not_active Expired - Lifetime
- 2003-03-14 WO PCT/FR2003/000821 patent/WO2003075956A2/fr active Application Filing
- 2003-03-14 CA CA002478846A patent/CA2478846A1/fr not_active Abandoned
- 2003-03-14 ES ES03727589T patent/ES2322253T3/es not_active Expired - Lifetime
- 2003-03-14 AT AT03727589T patent/ATE422366T1/de not_active IP Right Cessation
- 2003-03-14 AU AU2003233377A patent/AU2003233377A1/en not_active Abandoned
- 2003-03-14 JP JP2003574229A patent/JP2005527513A/ja active Pending
- 2003-03-14 DE DE60326128T patent/DE60326128D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2005527513A (ja) | 2005-09-15 |
ATE422366T1 (de) | 2009-02-15 |
AU2003233377A1 (en) | 2003-09-22 |
EP1487484A2 (de) | 2004-12-22 |
FR2837104A1 (fr) | 2003-09-19 |
WO2003075956A2 (fr) | 2003-09-18 |
CA2478846A1 (fr) | 2003-09-18 |
FR2837104B1 (fr) | 2004-08-06 |
WO2003075956A3 (fr) | 2004-04-08 |
ES2322253T3 (es) | 2009-06-18 |
EP1487484B1 (de) | 2009-02-11 |
AU2003233377A2 (en) | 2003-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20031687D0 (no) | Veksthormonsekretagoger | |
DE60334205D1 (en) | Heterocyclische sulfonamid-hepatitis-c-virus-hemmer | |
DE60324552D1 (en) | Substituierte cycloalkyl p1' hepatitis c virus inhibitoren | |
IS7533A (is) | Lifrarbólgu C-veirutálmar | |
DE60119968D1 (en) | Hepatitis c tripeptid inhibitoren | |
MXPA03000626A (es) | Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de la hepatitis c. | |
UA85536C2 (en) | Viral antigens | |
HK1088840A1 (en) | Stable analogs of glp-1 glp-1 | |
MXPA03000627A (es) | Nuevos peptidos como inhibidores de proteasa serina-ns3 del virus de la hepatitis c. | |
DK1511761T3 (da) | Fremgangsmåde til fremstilling af cykliske peptider | |
ATE555800T1 (de) | Zusammensetzung mit dem polyprotein ns3/ns4 und dem polypeptid ns5b von hcv, expressionsvektoren mit den entsprechenden nukleinsäuresequenzen und ihre therapeutische verwendung | |
DE60326128D1 (de) | Verwendung von mischungen von lipopeptiden zur bereitung von impfstoffen | |
AU2003220441A8 (en) | Dipeptidic growth hormone secretagogues | |
UY27030A1 (es) | Inhibidores del virus de hepatitis c | |
DK1572615T3 (da) | Fremgangsmåde til syntese af peptider indeholdende en 4-hydroxyprolin-substruktur |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |